Amgen
AMGN
2,721 hedge funds and large institutions have $119B invested in Amgen in 2023 Q4 according to their latest regulatory filings, with 345 funds opening new positions, 980 increasing their positions, 1,049 reducing their positions, and 89 closing their positions.
288% more first-time investments, than exits
New positions opened: 345 | Existing positions closed: 89
41% more capital inflows, than outflows
Capital inflows: $6.38B | Capital outflows: $4.53B
9% more funds holding
Funds holding: 2,504 → 2,721 (+217)
1.02% more ownership
Funds ownership: 75.95% → 76.97% (+1%)
6% less call options, than puts
Call options by funds: $1.91B | Put options by funds: $2.03B
7% less repeat investments, than reductions
Existing positions increased: 980 | Existing positions reduced: 1,049
9% less funds holding in top 10
Funds holding in top 10: 87 → 79 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$378M |
| 2 |
Neuberger Berman Group
New York
|
+$328M |
| 3 |
Morgan Stanley
New York
|
+$323M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$309M |
| 5 |
State Street
Boston,
Massachusetts
|
+$242M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$487M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$385M |
| 3 |
JP Morgan Chase
New York
|
-$265M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$207M |
| 5 |
Two Sigma Investments
New York
|
-$169M |
AMGN Hedge Fund Activity: Q4 2023 in Review
2,721 of the 6,880 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2023, worth a combined $119B — up 8.6% from $109B a quarter earlier.
Buyers outnumbered sellers: 345 funds opened new AMGN positions and 89 closed out — a net gain of 256 holders — while 980 added to existing stakes and 1,049 trimmed.
The largest buyer was Barclays, adding an estimated $378M. The largest seller was Capital Research Global Investors, cutting an estimated $487M.
- 2,721 institutional investors held Amgen (AMGN) as of Q4 2023, up from 2,504 in Q3 2023.
- Funds reported $119B of Amgen stock for Q4 2023, up 8.6% quarter-over-quarter.
- 345 funds opened new Amgen positions in Q4 2023 and 89 closed out, a net change of +256 holders.
- The largest Amgen buyer in Q4 2023 was Barclays, an estimated $378M added.
- The largest Amgen seller in Q4 2023 was Capital Research Global Investors, an estimated $487M sold.
Based on aggregated 13F filings for Q4 2023.